• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioLine RX Ltd

+ Add to Watchlist

BLRX:IT

56.90 ILs 0.70 1.22%

As of 10:24:19 ET on 09/23/2014.

Snapshot for BioLine RX Ltd (BLRX)

Open: 57.60 Day's Range: 55.00 - 57.90 Volume: 975,189
Previous Close: 57.60 52wk Range: 55.00 - 117.00 1-Yr Rtn: -28.96%

Stock Chart for BLRX

No chart data available.
  • BLRX:IT 56.20
  • 1D
  • 1M
  • 1Y
57.60
Interactive BLRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TA-100 -
Earnings Per Share (ILS) (ttm) -0.2120
Est. EPS (ILS) (12/2014) -0.1320
Est. PEG Ratio -
Market Cap (M ILS) 194.11
Shares Outstanding (M) 341.15
30 Day Average Volume 528,976
Price/Book (mrq) 1.7123
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLRX

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BLRX

BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.

Kinneret Livnat SavitskyChief Executive OfficerPhilip SerlinCFO/COO
David MalekVP:Business DevelopmentArnon AharonVP:Medical Affairs
More Company Profile & Key Executives for BLRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil